Economic burden of chronic kidney disease in Korea using national sample cohort

Springer Science and Business Media LLC - Tập 30 - Trang 787-793 - 2017
Seon-Ha Kim1, Min-Woo Jo2, Dun-Sol Go3, Dong-Ryeol Ryu4, Jongha Park5
1Department of Nursing, College of Nursing, Dankook University, Dongnam-gu, South Korea
2Department of Preventive Medicine, College of Medicine, University of Ulsan, Songpa-gu, South Korea
3Department of Public Health, Graduate School, Korea University, Seongbuk-gu, South Korea
4Department of Internal Medicine, School of Medicine, Ewha Womans University, Yangcheon-gu, South Korea
5Division of Nephrology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea

Tóm tắt

Determining the cost of a disease is one of the approaches to estimate the burden of the disease. This study was aimed to estimate the socioeconomic burden of chronic kidney disease (CKD) by CKD stages and treatment strategies in Korea. This was a population-based study designed to estimate the cost of CKD according to CKD stages and treatment strategies from a societal perspective in Korea using multiple data sources. Costs of CKD stages III, IV, and V, hemodialysis (HD), and peritoneal dialysis (PD) were estimated with a prevalence-based method. Costs of kidney transplantation (KT) and post kidney transplantation were estimated using an incidence-based method. Costs consisted of direct medical cost, productivity loss cost due to hospitalization and outpatient visit, caregiver cost, and transportation cost. Direct medical cost per year per patient with CKD stages III, IV, and V were 1205, 1963, and 8035 Euros, respectively. Direct medical cost per year per patient receiving HD and PD was 34,554 and 25,806 Euros, respectively. Medical cost per year per KT patient was 68,798 Euros. Direct medical cost which accounted for 70% of the total cost of CKD IV and 87% of the total cost of post KT. Cost associated with productivity loss was approximately 8–20%. Our findings could be useful for evaluating cost-effectiveness of various CKD interventions including the screening strategy. This study also emphasizes a remarkable increase in the socioeconomic burden associated with the progression of CKD in patients.

Tài liệu tham khảo

Global Burden of Disease Study (2013) Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995):743–800. doi:10.1016/S0140-6736(15)60692-4

Tonelli M, Riella M (2014) Chronic kidney disease and the ageing population. Nephron Clin Pract 128(3–4):319–322. doi:10.1159/000362458 (Epub 9 Dec 2014)

Ji E, Kim YS (2016) Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population. Korean J Intern Med. doi:10.3904/kjim.2015.193

National Health Insurance Corporation and Health Insurance Review and Assessment Service (2015) 2014 National Health Insurance statistical yearbook. http://www.nhis.or.kr/bbs7/boards/B0075/15288?boardKey=28&sort=sequence&order=desc&rows=10&messageCategoryKey=&pageNumber=1&viewType=generic&targetType=12&targetKey=28&status=&period=&startdt=&enddt=&queryField=&query=. Accessed 6 June 2016

National Health Insurance Corporation (2014) 2013 survey on the benefit coverage rate of National Health Insurance (Korean). http://kosis.kr/gen_etl/fileStat/fileStatView.jsp?org_id=350&tbl_id=DT_35005_FILE2013&tab_yn=Y&conn_path=I2. Accessed 10 Apr 2016

Statistics Korea Consumer Price Survey (Index) 2005 to 2013. http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1J0A001&conn_path=I2. Accessed 30 Apr 2016

Ministry of Employment and Labor. 2013 survey on labor conditions by employment type. http://kosis.kr/statHtml/statHtml.do?orgId=118&tblId=DT_LCE0001&conn_path=I2. Accessed 30 Apr 2016

Statistics Korea. 2013 economically active population survey. http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1DA7002&conn_path=I3. Accessed 30 Apr 2016

Roggeri DP, Roggeri A, Salomone M (2014) Chronic kidney disease: evolution of healthcare costs and resource consumption from predialysis to dialysis in Piedmont Region, Italy. Adv Nephrol. doi:10.1155/2014/680737 (Article ID 680737)

Villa G, Rodríguez-Carmona A, Fernández-Ortiz L et al (2011) Cost analysis of the Spanish renal replacement therapy programme. Nephrol Dial Transplant 26:3709–3714. doi:10.1093/ndt/gfr088

Stevens PE, Levin A; Kidney Disease (2013) Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M: evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158:825–830